Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.47
-0.52 (-1.93%)
Apr 29, 2026, 9:30 AM EDT - Market open
Immunovant Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 5,387 | 2,903 | 4,694 | 2,005 | 641 | 1,571 | |
| Market Cap Growth | 116.06% | -38.16% | 134.16% | 212.60% | -59.19% | 84.72% | |
| Enterprise Value | 4,499 | 2,528 | 4,004 | 1,574 | 117 | 1,153 | |
| Last Close Price | 26.99 | 17.09 | 32.31 | 15.51 | 5.51 | 16.04 | |
| PB Ratio | 5.56 | 4.10 | 7.60 | 5.53 | 1.37 | 4.01 | |
| P/TBV Ratio | 5.57 | 4.10 | 7.60 | 5.53 | 1.37 | 4.01 | |
| Debt / Equity Ratio | - | 0 | 0 | 0.00 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.03 | -1.03 | -1.05 | -1.01 | |
| Net Debt / EBITDA Ratio | 2.04 | 1.63 | 2.35 | 1.80 | 3.15 | 3.67 | |
| Net Debt / FCF Ratio | 2.35 | 1.90 | 2.96 | 1.99 | 4.62 | 4.75 | |
| Quick Ratio | 15.04 | 10.42 | 13.18 | 8.72 | 11.38 | 21.38 | |
| Current Ratio | 15.74 | 11.16 | 13.70 | 9.34 | 11.52 | 21.79 | |
| Return on Equity (ROE) | -69.35% | -62.46% | -52.91% | -50.69% | -36.39% | -44.25% | |
| Return on Assets (ROA) | -41.33% | -37.97% | -31.50% | -28.26% | -21.02% | -25.90% | |
| Return on Capital Employed (ROCE) | -49.40% | -61.90% | -43.70% | -57.40% | -33.10% | -27.50% | |
| Earnings Yield | -8.45% | -14.26% | -5.52% | -10.52% | -24.44% | -6.84% | |
| FCF Yield | -7.70% | -12.97% | -4.57% | -9.40% | -16.59% | -5.32% | |
| Buyback Yield / Dilution | -18.37% | -9.76% | -12.21% | -12.21% | -24.98% | -103.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.